SCHEMBL29599343

SCHEMBL29599343

Cn1ccc2cc(C(F)(F)F)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.53
CYP2A6 P11509 1/20 0.49
KCNH2 Q12809 1/20 0.45
KIF11 P52732 1/20 0.42
CHRNA7 P36544 2/20 0.41
PIK3CB P42338 1/20 0.41
HSD11B1 P28845 1/20 0.41
MAOB P27338 2/20 0.40
HTR7 P34969 1/20 0.40
HTR3E A5X5Y0 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HTR3B O95264 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
HTR1A P08908 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
HTR1D P28221 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16205315 1.00 PRKCI (0.53) PRKCICYP2A6KCNH2KIF11CHRNA7
SCHEMBL3995631 0.85 HTR7 (0.49) PRKCICYP2A6KIF11PIK3CBHTR7
SCHEMBL2627061 0.82 PRKCI (0.55) PRKCICYP2A6KCNH2PIK3CBHSD11B1
SCHEMBL18857011 0.78 KRAS (0.44) KCNH2HTR7HTR2C
SCHEMBL18856953 0.78 HTR7 (0.47) KCNH2HTR7KDM4EHTR2C
SCHEMBL16619618 0.77 CA2 (0.52) KCNH2KDM4EPKMCYP11B1CYP11B2
SCHEMBL22388515 0.77 PRKCI (0.49) PRKCICYP2A6KCNH2CHRNA7PIK3CB
SCHEMBL20655579 0.77 ALDH1A1 (0.44) KCNH2KIF11HTR7PKMCYP11B1
SCHEMBL22803948 0.76 HTR2B (0.59) MAOBKDM4ETP53CYP1A2CYP3A4
SCHEMBL4940378 0.75 CYP2A6 (0.44) CYP2A6KIF11HSD11B1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115322132-A N-substituted indole compound and synthetic method thereof 陕西科技大学 2022-11-11 CN disclosed
US-11304929-B2 Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11304929-B2 Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors PHGDH, G6PD, PHPT1 PRKCI 1364/4885CYP2A6 473/4885KCNH2 3070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.